1mr7: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /><applet load="1mr7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1mr7, resolution 1.80Å" /> '''Crystal Structure of... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1mr7.gif|left|200px]]<br /><applet load="1mr7" size=" | [[Image:1mr7.gif|left|200px]]<br /><applet load="1mr7" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="1mr7, resolution 1.80Å" /> | caption="1mr7, resolution 1.80Å" /> | ||
'''Crystal Structure of Streptogramin A Acetyltransferase'''<br /> | '''Crystal Structure of Streptogramin A Acetyltransferase'''<br /> | ||
==Overview== | ==Overview== | ||
Synercid, a new semisynthetic streptogramin-derived antibiotic containing | Synercid, a new semisynthetic streptogramin-derived antibiotic containing dalfopristin and quinupristin, is used in treatment of life-threatening infections caused by glycopeptide-resistant Enterococcus faecium and other bacterial pathogens. However, dissemination of genes encoding virginiamycin acetyltransferases, enzymes that confer resistance to streptogramins, threatens to limit the medical utility of the quinupristin-dalfopristin combination. Here we present structures of virginiamycin acetyltransferase D (VatD) determined at 1.8 A resolution in the absence of ligands, at 2.8 A resolution bound to dalfopristin, and at 3.0 A resolution in the presence of acetyl-coenzyme A. Dalfopristin is bound by VatD in a similar conformation to that described previously for the streptogramin virginiamycin M1. However, specific interactions with the substrate are altered as a consequence of a conformational change in the pyrollidine ring that is propagated to adjacent constituents of the dalfopristin macrocycle. Inactivation of dalfopristin involves acetyl transfer from acetyl-coenzyme A to the sole (O-18) hydroxy group of the antibiotic that lies close to the side chain of the strictly conserved residue, His-82. Replacement of residue 82 by alanine is accompanied by a fall in specific activity of >105-fold, indicating that the imidazole moiety of His-82 is a major determinant of catalytic rate enhancement by VatD. The structure of the VatD-dalfopristin complex can be used to predict positions where further structural modification of the drug might preclude enzyme binding and thereby circumvent Synercid resistance. | ||
==About this Structure== | ==About this Structure== | ||
1MR7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Enterococcus_faecium Enterococcus faecium]. Full crystallographic information is available from [http:// | 1MR7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Enterococcus_faecium Enterococcus faecium]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MR7 OCA]. | ||
==Reference== | ==Reference== | ||
| Line 14: | Line 14: | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Courvalin, P.]] | [[Category: Courvalin, P.]] | ||
[[Category: Kehoe, L | [[Category: Kehoe, L E.]] | ||
[[Category: Murray, I | [[Category: Murray, I A.]] | ||
[[Category: Rafferty, J | [[Category: Rafferty, J B.]] | ||
[[Category: Snidwongse, J.]] | [[Category: Snidwongse, J.]] | ||
[[Category: left-handed parallel beta-helix domain]] | [[Category: left-handed parallel beta-helix domain]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:58:12 2008'' | ||